Ibuprofen Max Aurovitas (Ibuprofen)

Ibuprofen works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes. This inhibition lowers prostaglandin synthesis, which in turn reduces inflammation, pain signaling, and fever generation at the site of injury.

The appropriate dose of Ibuprofen Max Aurovitas is determined by the prescribing healthcare professional based on the patient’s age, condition, and response. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for ibuprofen in pregnancy are limited, and it is generally avoided in the third trimester due to potential fetal risks. Breastfeeding mothers should consult their healthcare provider, as ibuprofen can pass into breast milk in small amounts.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibuprofen is a non‑selective NSAID offering a balance of analgesic, antipyretic, and anti‑inflammatory activity. Compared with selective COX‑2 inhibitors, ibuprofen may have a higher risk of gastrointestinal irritation but a lower cardiovascular risk profile. Choice of NSAID depends on individual patient factors and clinical judgment.

Store the product at ambient temperature, below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Ibuprofen Max Aurovitas is taken orally, usually with a full glass of water. It can be taken with or without food; however, taking it with food may reduce the chance of stomach upset.

Serious risks include gastrointestinal bleeding or ulceration, acute kidney injury, severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, and increased cardiovascular events in high‑risk patients. Patients should seek immediate medical attention if they experience signs of these conditions.

Individuals with a known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulcers, severe renal impairment, or in the third trimester of pregnancy should avoid using this product. Consultation with a healthcare professional is essential before starting therapy.